![]() ![]() In the third quarter, Novartis reported sales of 11.8 billion, up 12 year over year, and earnings per share (EPS) was 0. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars. FRANKFURT, Nov 28 (Reuters) - Novartis (NOVN. 1: Novartis' strong portfolio of drugs will drive revenue. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. Get the latest Novartis AG (NOVN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. ![]() The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. 95.93 -1.12 (-1.15) At close: Dec 7, 2023, 4:00 PM 95.91 -0.02 (-0. Novartis AG is a Switzerland-based pharmaceutical company. FISHER ASSET MANAGEMENT LLC Bought 544.3 Thousand shares of Novartis AG: Top 10 Owners of Novartis AG.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |